Roche, Cipla Launch Antibody Cocktail Casirivimab and Imdevimab in India. Check Price, Details

Roche, Cipla Launch Antibody Cocktail Casirivimab and Imdevimab in India. Check Price, Details New Delhi: Drug majors Roche India and Cipla launched Roche’s Antibody Cocktail (Casirivimab and Imdevimab) in India today for the treatment of mild to moderate COVID-19 in patients who are at high risk. “The first batch of the Antibody Cocktail is now available…